Clinical trial · Observational
Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging
Preoperative Prediction of the Pathological Classification of Thymic Epithelial Tumors by Apparent Diffusion Coefficient Using Ultra-high B-values
NCT03212027CI-TRIAL-00028656unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to analyze aquaporins expression of thymic epithelial tumors and to compare them with apparent diffusion coefficient(ADC) from ultra-high b-values, and to test a possibility of use of ADCuh to identify the pathological type of tumor.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thymic Epithelial Tumor | Thymus Epithelial Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- Patients with low-risk thymomas
- description
- low-risk thymomas include types A, AB, and B1 thymomas
- label
- Patients with high-risk thymomas
- description
- high-risk thymomas include types B2 and B3 thymomas
- label
- Patients with thymic carcinomas
- description
- thymic carcinomas also called types C thymomas
Primary outcomes (1)
- measure
- Different DWI parameters in thymic epithelial tumors
- timeFrame
- 6 months
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * no use of corticosteroid drugs; * no MRI contraindication; * no infection or fever; * tumor diameter is greater than 2cm. Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.